Business Wire

Evernote Releases v11, Marking a New Chapter in AI-Powered Productivity

19.1.2026 18:00:00 EET | Business Wire | Press release

Share

Evernote today announced the release of v11, its first major product update in five years. The new version includes three powerful AI features—AI Assistant, Semantic Search, and AI Meeting Notes—creating smarter ways to capture, retrieve, and manage information in Evernote. With the release of v11, these features are now available to all Evernote customers.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260119103272/en/

Two years of work culminating in a major update

V11 is a recognition of Evernote’s evolution under Bending Spoons’ stewardship. Since 2024, Evernote has released more than 250 new features and improvements while also greatly enhancing sync, speed, and reliability. With v11, Evernote ushers in an exciting new phase of development and innovation, bringing customers novel ways to engage with their preferred productivity tool.

“Evernote has been part of people’s lives for years, often decades. They’ve always inspired and shaped how our platform evolves,” said Federico Simionato, product lead at Evernote. “Through hundreds of interviews and workshops we designed v11’s AI features to make people’s everyday needs of capturing, organizing and retrieving information in Evernote more intuitive and efficient than ever.”

Powerful new AI features

V11’s three new AI features—AI Assistant, Semantic Search, and AI Meeting Notes—build directly on Evernote’s core workflows while remaining adaptive to each user’s unique way of working and thinking. Anyone can unlock more powerful note-taking, organization, and productivity, regardless of their previous experience using Evernote.

AI Assistant—developed in close collaboration with OpenAI—brings conversational intelligence directly into Evernote, enabling users to interact with their notes, tasks, and calendar through a dedicated chat interface. By helping people summarize content, surface relevant information, and search the web for insights, AI Assistant makes everyday workflows more productive.

Semantic Search introduces a long-requested new search experience. Now, it’s possible to use natural language queries to surface relevant notes and key details, without the need for exact keyword matching. As a result, users can access the necessary information in their accounts quickly and efficiently.

AI Meeting Notes records, transcribes, and summarizes in-person and online meetings directly within Evernote, with support for multiple speakers. By capturing conversations accurately and generating summaries with key action items, AI Meeting Notes help users stay focused during meetings and make it easy to revisit important information afterwards.

To give users greater control over their experience, individual AI features can be enabled or disabled via new settings. As of release, AI Assistant is available on Evernote Desktop and Web only, while Semantic Search and AI Meeting Notes are available on Desktop, Web, and Mobile.

Read more about v11’s AI features at evernote.com.

Building the future of Evernote beyond AI

In addition to new AI capabilities, v11 includes improvements to the core functions of Evernote, including note editing, capture, and navigation. With v11, Evernote also introduces a refreshed Evernote brand identity, including an updated logo and a modernized visual language. The new design reflects the evolution of the brand while preserving its core identity.

V11 is rolling out to all Evernote users starting January 19, 2026.

About Evernote

Evernote is the leading productivity app designed to help people capture, organize, and act on their ideas. Used by millions worldwide, Evernote brings notes, tasks, documents, and schedules together in one flexible workspace, making it easier to stay focused and productive across devices.

Learn more at evernote.com.

About Bending Spoons

Bending Spoons acquires and transforms digital businesses. It owns Brightcove, Evernote, komoot, Meetup, Remini, StreamYard, WeTransfer, Vimeo and many others. The company’s products have served more than a billion people, with over 400 million monthly active users and 10 million paying customers, including most Fortune 500 enterprises. Learn more at bendingspoons.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260119103272/en/

Contacts

Media contacts
Evernote:
Rebecca Shamritsky
rebs@bendingspoons.com

Bending Spoons:
Christy Keenan
ck@bendingspoons.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

IQM Delivers Fourth Quantum Computer in Finland, Operational at Aalto University11.3.2026 12:32:00 EET | Press release

IQM Quantum Computers, the global leader in deployed on-premises, full-stack superconducting quantum computers, today announced the launch of Aalto Q20 quantum computer in Finland, reinforcing its commercial leadership in the quantum industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260311215316/en/ Ribbon cutting of the Aalto Q20 quantum computer delivered by IQM. The 20-qubit system, which is operational at Aalto University, is the fourth quantum computer deployed by IQM in Finland, marking a milestone in the country’s growing quantum technology ecosystem. Finland has recently been characterized as the number two global quantum cluster and is amongst the top five countries for quantum patent applications. “When institutions like Aalto University own their quantum computers, it means their data, their IP, and their expertise stay theirs. That’s not a feature — that’s a strategic posture to enable world-class research

Chiesi and Bespak Partner to Advance Carbon Minimal Inhaler Production With UK Manufacturing Site11.3.2026 12:00:00 EET | Press release

Chiesi Group ("Chiesi"), the international research focused biopharmaceutical company and a certified B Corp, and Bespak, the specialist inhalation CDMO focused on pulmonary and nasal drug delivery, today announced an expansion of their long-standing partnership, increasing pressurized metered dose inhaler (pMDI) manufacturing capacity at Bespak’s Holmes Chapel site to support the next phase of Chiesi’s Carbon Minimal Inhaler (CMI) program. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260311319953/en/ Chiesi Group ("Chiesi"), the international research focused biopharmaceutical company and a certified B Corp, and Bespak, the specialist inhalation CDMO focused on pulmonary and nasal drug delivery, today announced an expansion of their long-standing partnership, increasing pressurized metered dose inhaler (pMDI) manufacturing capacity at Bespak’s Holmes Chapel site to support the next phase of Chiesi’s Carbon Minimal Inhaler

NTT DATA Unveils NVIDIA-Powered Enterprise AI Factories to Support Secure AI Adoption and Help Clients Drive Measurable ROI11.3.2026 12:00:00 EET | Press release

NTT DATA, a global leader in AI, digital business and technology services, announced an initiative to deliver NVIDIA-powered enterprise AI factories that drive innovation and operational excellence for organizations worldwide. NTT DATA’s new enterprise AI factories provide full-stack, domain-specific solutions that integrate data, infrastructure, workflows and governance to give organizations a repeatable and production-ready operating model for enterprise AI. NTT DATA enterprise AI factories, powered by NVIDIA, are adaptive, intelligent and automated ecosystems designed to help clients accelerate return on investment by scaling enterprise AI efficiently and managing the full AI lifecycle end to end. The company’s new enterprise AI factories integrate the NVIDIA AI infrastructure—combining GPU-accelerated computing and high-performance networking—with NVIDIA AI Enterprise software, including NVIDIA NIM microservices, to deliver high‑throughput, low‑latency AI that can be deployed consi

Haleon Strengthens Commitment to China as Consumers Focus on Better Everyday Health11.3.2026 11:00:00 EET | Press release

Haleon, a consumer company that is solely focused on better everyday health, is investing £65 million in a new state-of-the-art oral health manufacturing site in Shanghai. The facility will support the expansion of its oral care portfolio – which includes the global brands Sensodyne and parodontax – into China’s fast-growing tier 2 and tier 3 cities, where rising incomes, growing awareness of everyday health and a shift towards trusted, branded products are reshaping consumer behaviour. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260311389622/en/ parodontax, Haleon's clinically proven gum health brand, is expanding across China As part of this shift, more consumers are embedding preventative oral care into their daily self-care routines, and demand for premium, science-backed solutions is accelerating at a rapid pace. This investment strengthens Haleon’s local manufacturing footprint and positions the business to capture

Eurofins Biomnis Launches New Clinical LC‑MS/MS Method for the Detection of Cereulide Toxin in Stool Samples11.3.2026 10:00:00 EET | Press release

Eurofins Biomnis, a leading European provider of specialised clinical diagnostics services, and part of the global network of Eurofins laboratories, announces the successful development and validation of a new liquid chromatography tandem mass spectrometry (LC‑MS/MS) method for the detection and quantification of cereulide toxin in human stool samples. This innovation underlines Eurofins Biomnis’ diagnostic innovation, and its commitment to contributing its expertise to reducing diagnostic uncertainty with solutions that support clinicians and laboratories nationwide and internationally. Eurofins Biomnis has fully validated the method for human stool samples, taking into account matrix effects and meeting the requirements of ISO 15189 (with the exception of inter‑method comparison on pathological clinical samples). Cereulide, a toxin produced by specific strains of Bacillus cereus, has recently raised significant public attention following contamination events involving infant formula

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye